Studies offer valuable advice on stone prevention

Up to 5% of Americans will be affected by stone disease over the courseof their lifetime. Despite major advances in shockwave lithotripsy and endoscopictechnologies, we must not underestimate the role of medical therapy in preventingstone recurrence. Two studies presented at the recent AUA annual meetingand reported in this issue of Urology Times (see page 10) offer valuablelessons on this aspect of stone management.

Related Videos

Related Content

Advertisement

February 3rd 2025

Hundreds of future urologists celebrate Urology Match Day 2025

Hannah Clarke

Overall, 403 medical students and other applicants were matched across 148 urology residency programs nationwide.

March 21st 2024

Health policy in urology: 2024 AUA Advocacy Summit recap

Urology Times staff

In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy and recap the AUA's recent Annual Urology Advocacy Summit.

January 27th 2025

Clarifying coding for percutaneous nephrolithotomy procedures

Jonathan Rubenstein, MD Mark Painter

"From a coding standpoint and from the work performed and valuation of the work and descriptors, it is appropriate to report the dilation (50436 without or 50437 with new access as appropriate) along with the nephrolithotomy codes (50080/50081) when both are performed at the same time by the same provider," write Jonathan Rubenstein, MD, and Mark Painter.

August 28th 2023

How APPs can bridge the gap in urologist shortages

Urology Times staff

In this episode, Janelle Bunce, PA-C, highlights the role that advanced practice providers can play in filling the gaps created by the growing workforce shortages in urology.

January 18th 2025

Leveraging the full potential of APPs: Mark Edney, MD, on tips for successful collaboration

Mark T. Edney, MD

"There are far more people presenting to us for care than we have people able to provide it. The APPs are going to be a critical part of trying to solve that puzzle," says Mark T. Edney, MD.

December 31st 2024

Urology Coding Q&A: Can G2211 be reported regardless of payer?

Jonathan Rubenstein, MD Mark Painter

"If a practice has determined in writing that there are insurers whose policies advised that they will not accept this code, it seems reasonable not to report that code to that insurer even when criteria are met," write Jonathan Rubenstein, MD, and Mark Painter.

Related Content

Advertisement

February 3rd 2025

Hundreds of future urologists celebrate Urology Match Day 2025

Hannah Clarke

Overall, 403 medical students and other applicants were matched across 148 urology residency programs nationwide.

March 21st 2024

Health policy in urology: 2024 AUA Advocacy Summit recap

Urology Times staff

In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy and recap the AUA's recent Annual Urology Advocacy Summit.

January 27th 2025

Clarifying coding for percutaneous nephrolithotomy procedures

Jonathan Rubenstein, MD Mark Painter

"From a coding standpoint and from the work performed and valuation of the work and descriptors, it is appropriate to report the dilation (50436 without or 50437 with new access as appropriate) along with the nephrolithotomy codes (50080/50081) when both are performed at the same time by the same provider," write Jonathan Rubenstein, MD, and Mark Painter.

August 28th 2023

How APPs can bridge the gap in urologist shortages

Urology Times staff

In this episode, Janelle Bunce, PA-C, highlights the role that advanced practice providers can play in filling the gaps created by the growing workforce shortages in urology.

January 18th 2025

Leveraging the full potential of APPs: Mark Edney, MD, on tips for successful collaboration

Mark T. Edney, MD

"There are far more people presenting to us for care than we have people able to provide it. The APPs are going to be a critical part of trying to solve that puzzle," says Mark T. Edney, MD.

December 31st 2024

Urology Coding Q&A: Can G2211 be reported regardless of payer?

Jonathan Rubenstein, MD Mark Painter

"If a practice has determined in writing that there are insurers whose policies advised that they will not accept this code, it seems reasonable not to report that code to that insurer even when criteria are met," write Jonathan Rubenstein, MD, and Mark Painter.